Actively Recruiting
EKO SENSORA: Detecting Clinically Significant Murmurs
Led by Corewell Health South · Updated on 2025-12-12
300
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the Eko SENSORA device, which uses artificial intelligence to detect clinically significant heart murmurs. This device records heart sounds via a digital stethoscope and analyzes them with machine learning to identify abnormalities. The study focuses on patients presenting with symptoms such as chest pain, fatigue, shortness of breath, or syncope, which can indicate heart problems. The goal is to improve detection of valvular heart disease in an emergency department setting. Participants will have their heart sounds recorded using the Eko SENSORA device placed on key areas of the chest for 15 to 30 seconds until a green light signals a good recording. The sounds are uploaded via Wi-Fi to an AI system that analyzes them without patient identifiers. The device then indicates if a significant heart murmur is present and specifies the recording location. This is an interventional study where the device's performance is being assessed. During the study, participants will be monitored for an average of 90 days to measure the number of new clinically significant heart murmurs detected. Researchers will also track the number of echocardiograms ordered. The study involves patients with cardiac risk factors and symptoms suggesting possible heart dysfunction. The device’s results and related clinical decisions will be recorded to assess its usefulness in the emergency department setting.
CONDITIONS
Brief Title
EKO SENSORA: Detecting Clinically Significant Murmurs
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years or older
- Presenting with chest pain, shortness of breath, difficulty breathing, or syncope/near-syncope
- Patients with weakness are eligible if over 50 years old and have at least two of hypertension, BMI ≥ 30, diabetes, hyperlipidemia, atrial fibrillation, heart attack, stroke/transient ischemic attack, prior cardiac surgery, or angiography
You will not qualify if you...
- Patients under contact isolation
- Pediatric patients under 18 years old
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 90 days
Participants are monitored to detect clinically significant heart murmurs using the Eko Sensora device over an average of 90 days.
Participants have heart sound recordings taken during usual care; no specific visit schedule is required.
Trial Site Locations
Total: 1 location
1
Corewell Health Lakeland
Saint Joseph, Michigan, United States, 49085
Actively Recruiting
Research Team
M
Monique Luna, MS
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here